Sinovac Vaccine Will Be Allocated For The National Army And Police Task Force At The End Of February After Being Tested By National Agency of Drug and Food Control

AstraZeneca Vaccine. (Source: Wikimedia Commons / Agencia Brasilia)

JAKARTA - PT Bio Farma revealed that the COVID-19 vaccine for public service workers, including The National Army and Police Task Force will be allocated at the end of February 2021.

Bio Farma spokesman Bambang Heriyanto said the National Agency of Drug and Food Control would issue the test results in the form of a lab release for the COVID-19 vaccine that has been produced by Bio Farma.

The first batch or wave is expected to be completed in the second week of February 2021.

"The finished vaccine is planned to be allocated to public officials and public service personnel, including the National Army and Police Task Force starting at the end of February 2021", said Bambang Heriyanto at Soekarno Hatta Airport, Tangerang, as reported by Antara, Tuesday, February 2.

All raw materials or bulk of the COVID-19 vaccine, after being processed into a vaccine must first go through a series of rigorous quality tests conducted by the Bio Farma laboratory and the National Agency of Drug and Food.

This aims to ensure that the vaccines produced meet the established quality and quality standards.

"In order to maintain the quality of the vaccines, Bio Farma uses an integrated vaccine distribution system equipped with an Internet of Things (IoT) dashboard in the process", said Bambang.

Furthermore, the Bio Farma spokesperson explained to note that the COVID-19 vaccine packaging this time will be named COVID-19 Vaccine, which has a different packaging from the previously distributed vaccine, CoronaVac.

The previous three million CoronaVac vaccine packs were packaged in a single dose where one vial contained one dose, in one box containing 40 vials so that one box contained 40 doses.

Meanwhile, the COVID-19 vaccine, which is currently being processed at Bio Farma, will later be packaged in multidose packages where one vial contains 10 doses, and in one box will be packaged in 10 vials so that one box contains 100 doses.

"That is the difference in packaging, but it does not differentiate the quality of the COVID-19 vaccine", said Bambang.